GTC
CABA icon

Ghost Tree Capital’s Cabaletta Bio CABA Stock Holding History

Ghost Tree Capital’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-370,899
Closed -$2.77M – 62
2024
Q2 		$2.77M Sell
370,899
-4,101
-1% -$50.3K 0.87% 40
2024
Q1 		$6.4M Buy
375,000
+225,000
+150% +$4.83M 1.77% 20
2023
Q4 		$3.4M Buy
+150,000
New +$2.52M 1.11% 30
2022
Q1 		– Sell
-135,000
Closed -$512K – 45
2021
Q4 		$512K Buy
135,000
+35,000
+35% +$373K 0.18% 46
2021
Q3 		$1.22M Buy
+100,000
New +$922K 0.36% 55

Other funds holding CABA

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Ghost Tree Capital's CABA Position: Q3 2024 in Review

Ghost Tree Capital sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 370,899 shares — an estimated $2.77M sold.

Ghost Tree Capital first reported a position in CABA in Q3 2021 and held it in 5 quarters. The position peaked at $6.4M in Q1 2024. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

  • Ghost Tree Capital reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
  • Ghost Tree Capital sold 370,899 Cabaletta Bio shares in Q3 2024, an estimated $2.77M.
  • Ghost Tree Capital first reported a position in Cabaletta Bio in Q3 2021 and held it in 5 quarters.
  • Ghost Tree Capital's Cabaletta Bio position peaked at $6.4M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.